drugset / Trial / NCT06316076
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy of CD19-CAR-DNT cells in subjects with relapsed/refractory autoimmune diseases
Timeline
- Start
- 2023-10-30
- Primary completion
- 2024-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD19-CAR-DNT Cells | Cell therapy | — | — |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Fludarabine | Small molecule | — | — |